MedPath

comparisson of gabapentne and pregabalin in controling of opioid withdrawal

Not Applicable
Conditions
Opium Dependency.
Mental and behavioural disorders due to use of opioids
Registration Number
IRCT201707252266N7
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

having DSM-V criteria for drug dependence; regular orally/smoking daily consumption of opium; using no other medication including psychiatric drugs and also other substances except cigarette; not taking pain medications; absence of other comorbid psychiatric disorders; not having any special disease which causes opium withdrawal prohibition; no contraindication for pregabalin and gabapentin consumption .
Exclusion criteria : lack of patients' interest for participation and continuation of study; any ethical or medical conflict for continuation; incidence of any physical/mental complication that needs special interventions.
;pregnancy and brestfeeding.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of opium withdrawal. Timepoint: first, 7th, 15th and 22th days. Method of measurement: Qustionair.
Secondary Outcome Measures
NameTimeMethod
Drugs sideffects. Timepoint: first, 7th, 15th, 22th days. Method of measurement: check list.
© Copyright 2025. All Rights Reserved by MedPath